IRB Barcelona logo

News

Highlighting IRB Barcelona's impact on society

News

Emili Bargalló (Fundació Sant Joan de Déu), Carme Verdaguer (Bosch i Gimpera), Marc Ramis (Chasing Science), Meritxell Teixidó (Gate2Brain), Esther Riambau (Gate2Brain), Francesc Posas (IRB Barcelona)
Innovation
Launch of Gate2Brain, the “key” to transporting drugs into the brain and improving their effectiveness
Scientific - Published in Science Advances
80% of the cancer cell lines used in research closely resemble their tissue-of-origin
After APP cleavage at the neuronal membrane, Aβ protein self-assembles into 4 or 8 copies adopting an arrangement allowing passage of water and ions (in red) and thus disrupting ion cell homeostasis © Benjamin Bardiaux.
Scientific - Published in Nature Communications
A new mechanism of toxicity in Alzheimer's disease 
revealed by the 3D structure of Aβ protein assemblies
Oriol Pich, PhD student at IRB Barcelona.
Community
An interview with Oriol Pich, Medical Doctor and PhD student in Computational Biology at IRB Barcelona
DNA lesions. Credit: Petra Korlevic
Scientific - Published in Nature
Unpicking the complexity of DNA mutations
Representatives of investment funds on the signing of the Series A Ona. Francesc Posas, Emilià Pola, Joël Jean-Mairet, Clara Campàs,Salvador Aznar-Benitah, Valerie Vanhooren and Montserrat Vendrell.
Innovation
Ona Therapeutics raises €30M in Series A financing
Community
So far, so close...
Scientific - Published in Nature Medicine
A role of colibactin-producing E. coli in carcinogenesis
Innovation
Iproteos, IRB Barcelona’s spin-off specialised in drugs to treat diseases of the central nervous system, is taken over by Accure Therapeutics

Media Mentions

Blog

Do you want to be informed?

Visit our blog.

IRB Blog